ReviewInternational urogynecology journal2026
Efficacy and Safety of Energy-Based Device Therapy in Women Diagnosed with Vaginal Relaxation Syndrome: A Systematic Review and Meta-analysis.
Review in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of bipolar radiofrequency in the treatment of vaginal laxity: a single-center cohort study in premenopausal women.Lasers in medical science · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introduction and hypothesisTo evaluate the efficacy and safety of energy-based devices (EBDs) in the treatment of vaginal relaxation syndrome (VRS).
methodsSystematic search of PubMed, EMBASE, Web of Science, MEDLINE, Clinicaltrials.gov, and Cochrane Library through September 2024. Studies were eligible if they evaluated EBDs for the management of VRS and reported outcomes related to treatment efficacy, side effects, and follow-up data. Two reviewers independently screened titles, abstracts, and full texts, extracted data, and assessed study quality. Meta-analyses were performed when appropriate. This systematic review was conducted and reported in accordance with the PRISMA guidelines.
resultsThirty-four studies (7 RCTs, 27 OSs; 1775 participants) were included. RCTs showed improvement in Female Sexual Function Index (FSFI) and Vaginal Laxity Questionnaire (VLQ) scores after laser or radiofrequency (RF) treatment (P > 0.05). OSs demonstrated significant increases in FSFI, VLQ, and Vaginal Health Index scores (all P < 0.05). RF improved Sexual Satisfaction Questionnaire and Female Sexual Distress Scale-Revised scores (P < 0.05). PISQ-12 scores also improved posttreatment (P < 0.05). Mild side effects resolved within 1-2 days.
conclusionCurrent evidence, which mainly comes from observational studies with substantial bias, suggests that EBDs improve vaginal health and sexual function in women with VRS. However, owing to limitations in study quality, further high-quality, large-scale RCTs are needed.
Indexed as
Identifiers
42274731What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.